Hematology NewsFirst NCCN guideline on hematopoietic cell transplantation focuses on GVHDNovember 5, 2019TransplantationPatient & Survivor CareTransplant
Oncology PracticeLevothyroxine dose for checkpoint inhibitor toxicity may be too highNovember 4, 2019MelanomaLung CancerPatient & Survivor CareImmunotherapy
Oncology PracticeFDA proposes new breast implant labeling with a boxed warningOctober 24, 2019Patient & Survivor CareLymphoma & Plasma Cell Disorders
Oncology PracticeHow to overcome barriers to exercise for cancer patientsOctober 23, 2019Patient & Survivor Care
Hematology NewsExercise intolerance linked to neurocognitive dysfunction in ALLOctober 22, 2019ALLLeukemia, Myelodysplasia, TransplantationPatient & Survivor Care
The law of unintended consequencesOctober 11, 2019Gynecologic CancerPatient & Survivor CareLung Cancer
Oncology PracticePatient-reported outcomes are here to staySeptember 27, 2019Practice ManagementBusiness of MedicinePatient & Survivor Care
Oncology PracticeAF risk is elevated after early-stage breast cancer diagnosisSeptember 27, 2019Breast CancerPatient & Survivor Care
Oncology PracticeCancer patients increasingly being discharged to subacute rehabilitation facilitiesSeptember 12, 2019Practice ManagementImmuno-oncologyPatient & Survivor Care
Oncology PracticePrior antibiotic use lowers checkpoint inhibitor response and survivalSeptember 12, 2019Immuno-oncologyLung CancerPatient & Survivor CareMelanoma
Oncology PracticeChemotherapy may raise CVD risk in pediatric cancer survivorsSeptember 8, 2019PediatricsPatient & Survivor Care
